Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Social Media Group Reviewing Its First iPhone App As DTC Marketing Tool, But It's Not The First To Be Released

Executive Summary

FDA has started wading into the iPhone business, at least to help determine how drug companies can use the App Store. FDA's social media working group is reviewing its first submission for an iPhone app as a direct-to-consumer marketing tool, Division of Drug Marketing, Advertising and Communications special assistant Jean-Ah Kang told the DTC National Conference April 9

You may also be interested in...



Downloading Confusion: Are Mobile Drug Dose Calculators Medical Devices?

Biopharmaceutical companies are expressing concern that a recent FDA draft guidance on mobile applications could force drug firms offering apps such as drug dose calculators to register and be regulated as medical device manufacturers.

Downloading Confusion: Are Mobile Drug Dose Calculators Medical Devices?

Biopharmaceutical companies are expressing concern that a recent FDA draft guidance on mobile applications could force drug firms offering apps such as drug dose calculators to register and be regulated as medical device manufacturers.

FDA's Internet Promotion Guidance: One Down By Year-End; Four More To Go?

DDMAC is nearing completion of the first in what is expected to be a series of guidance documents pertaining to appropriate drug promotion on the Internet and with social media tools.

Related Content

Topics

UsernamePublicRestriction

Register

PS052138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel